Literature DB >> 2155476

Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis.

E Seppälä1, M Nissilä, H Isomäki, H Wuorela, H Vapaatalo.   

Abstract

Altogether 53 patients (31 women, 22 men) with definite rheumatoid arthritis were randomly divided into groups of 5-6 patients and treated for one day only with one of the following non-steroidal anti-inflammatory drugs (NSAIDs): acetylsalicylic acid, carprofen, diclofenac, indomethacin, naproxen, proquazone, timegadine, tolfenamic acid or paracetamol, and with prednisolone, in recommended doses. Synovial fluid samples were collected before and after the treatment. White cell count and its differentiation as well as the concentrations of protein, cyclic adenosine-3',5'-monophosphate (cAMP), prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) were measured from the synovial fluid. Synovial fluid leukocyte counts correlated with PGE2 concentrations, but showed no correlation with LTB4 levels before treatment. Significant changes were seen in the form of lowered PGE2 values following treatment with the clinically and experimentally most potent NSAIDs, and as depressed LTB4 levels following prednisolone treatment. The other markers of inflammation are obviously more resistant, changing only slowly during prolonged treatment, and may thus be, at least in part, secondary to the changes in prostanoids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155476     DOI: 10.3109/03009749009092624

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  10 in total

Review 1.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

3.  Prognostic factors associated with improved outcome of Escherichia coli bacteremia in a Finnish university hospital.

Authors:  A Kuikka; A Sivonen; A Emelianova; V V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

4.  Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol.

Authors:  B Bannwarth; P Netter; F Lapicque; P Gillet; P Péré; E Boccard; R J Royer; A Gaucher
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

5.  Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.

Authors:  Trevor Duffy; Orina Belton; Barry Bresnihan; Oliver FitzGerald; Desmond FitzGerald
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Impact of cAMP on the T-cell response to type II collagen.

Authors:  Patricia Ozegbe; Andrew D Foey; Salman Ahmed; Richard O Williams
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

7.  Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.

Authors:  P Bertin; F Lapicque; E Payan; M Rigaud; F Bailleul; S Jaeger; R Treves; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies.

Authors:  George Robinson; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 14.808

Review 9.  COX-2 inhibitors in rheumatoid arthritis.

Authors:  J S Sundy
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686

10.  Epithelium-specific Ets transcription factor-1 acts as a negative regulator of cyclooxygenase-2 in human rheumatoid arthritis synovial fibroblasts.

Authors:  Chan-Mi Lee; Sahil Gupta; Jiafeng Wang; Elizabeth M Johnson; Leslie J Crofford; John C Marshall; Mohit Kapoor; Jim Hu
Journal:  Cell Biosci       Date:  2016-06-16       Impact factor: 7.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.